Evaluating the Effects of <i>Crocus sativus</i> L. Herbal Product on Chronic Fatigue Syndrome in Patients with Chronic Obstructive Pulmonary Disease: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. — ME/CFS Atlas
E1 ReplicatedModerate confidencePEM not requiredRCTPeer-reviewedReviewed
Standard · 3 min
Evaluating the Effects of Crocus sativus L. Herbal Product on Chronic Fatigue Syndrome in Patients with Chronic Obstructive Pulmonary Disease: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial.
Dastan, Farzaneh, Salamzadeh, Jamshid, Heshmatnia, Jalal et al. · Iranian journal of pharmaceutical research : IJPR · 2025 · DOI
Quick Summary
This study tested whether saffron extract could help reduce extreme tiredness in people who have both COPD (a lung disease) and chronic fatigue syndrome. Researchers gave one group of patients saffron capsules twice daily for 8 weeks, while another group received a placebo (dummy pill). The saffron group showed significant improvement in fatigue and quality of life compared to the placebo group.
Why It Matters
This study is relevant because ME/CFS and CFS in COPD patients both involve debilitating fatigue with limited treatment options. Identifying even modest interventions that reduce fatigue burden without adverse effects could improve quality of life for patients with severe, unexplained chronic fatigue. The rigorous RCT design provides stronger evidence than observational studies for evaluating potential adjunctive treatments.
Observed Findings
Saffron extract significantly improved Chronic Respiratory Questionnaire total scores compared to placebo (P < 0.001)
Manchester COPD Fatigue Scale scores showed significant improvement with saffron intervention (P < 0.001)
St. George's Respiratory Questionnaire total quality of life scores improved significantly with saffron (P = 0.012)
Saffron did not significantly reduce dyspnea (breathlessness) or respiratory symptoms (P = 0.38 and P = 0.158 respectively)
37 patients completed the intervention group and 34 completed the control group over 8 weeks
Inferred Conclusions
Crocus sativus herbal product is effective in reducing chronic fatigue and improving quality of life in COPD patients with secondary fatigue
Saffron may selectively improve fatigue without addressing underlying COPD respiratory pathology
The herbal product warrants further investigation as a potential adjunctive fatigue intervention
Remaining Questions
Does saffron's benefit extend to ME/CFS patients without concurrent COPD, and if so, with what efficacy?
What is the mechanism of action by which saffron reduces fatigue—is it anti-inflammatory, metabolic, or neurological?
What This Study Does Not Prove
This study does not prove saffron is effective for ME/CFS in the general population, as participants were specifically COPD patients with secondary fatigue—a potentially different condition from primary ME/CFS. The study cannot determine the mechanism of saffron's action or whether benefits would persist beyond 8 weeks. It also does not establish whether saffron addresses post-exertional malaise or other ME/CFS-specific symptoms.
Tags
Symptom:Fatigue
Method Flag:Weak Case DefinitionSmall SampleMixed Cohort
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.